ProQR (PRQR) Prices 13.846M Share Common Offering at $6.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
After-Hours Stock Movers 03/30: (SURF) (CASI) (CHWY) Higher; (NMTR) (OSMT) (BB) Lower (more...)
March 30, 2021 5:42 PM EDTAfter-Hours Stock Movers:
Surface Oncology (Nasdaq: SURF) 14.5% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for one of the companys lead therapeutic candidates, SRF617, for the treatment of patients with pancreatic cancer.
ProQR (PRQR) Announces Proposed Underwritten Public Offering of Ordinary Shares
March 30, 2021 4:06 PM EDTProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced that it intends to offer and sell its ordinary shares in an underwritten public offering. All... More



